Alternatively spliced HPV-18 E6(*) protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

Oncogene

Volumn 15, Issue 3, 1997, Pages 257-264

  Pim, David ^a   Massimi, Paola ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

E6; HPV; p53; Transformation

Indexed keywords

PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CELL TRANSFORMATION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA SPLICING; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030794825     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201202     Document Type: Article

References (44)

1. Androphy EJ, Hubbert NL, Schiller JT and Lowry DR. (1987). EMBO J., 6, 989-992.
2. Banks L, Matlashewski G and Crawford L. (1986). Eur. J. Biochem., 159, 529-534.
3. Banks L, Spence P, Androphy E, Hubbert N, Matlashewski G, Murray A and Crawford L. (1987). J. Gen. Virol., 68, 1351-1359.
4. Barak Y, Gottlieb E, Juver-Gershon T and Oren M. (1994). Genes Dev., 8, 1739-1749.
5. Barbosa MS and Schlegel R. (1989). Oncogene, 4, 1529-1532.
6. Bohm S, Wilczynski SP, Pfister H and Iftner T. (1993). Int. J. Cancer, 55, 791-798.
7. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A and Hoppe-Seyler F. (1995). Oncogene, 10, 927-936.
8. Cheng S, Schmidt-Grimminger, D-C, Murant T, Broker TR and Chow LT. (1995). Genes Dev., 9, 2335-2349.
9. Chow LT, Nasseri M, Wolinsky SM and Broker TR. (1987). J. Virol., 61, 2581-2588.
10. Crook T, Tidy JA and Vousden KH. (1991). Cell, 67, 547-556.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
12. Doorbar J, Parton A, Hartley K, Banks L, Crook T, Stanley M and Crawford L. (1990). Virology, 178, 254-262.
13. Dyson N, Howley PM, Munger K and Harlow E. (1989). Science, 243, 934-937.
14. Grassmann K, Rapp B, Maschek H, Petry KU and Iftner T. (1996). J. Virol., 70, 2339-2349.
15. Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. (1995). Genes Dev., 9, 2170-2183.
16. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT. (1989). EMBO J., 8, 3905-3910.
17. Huibregtse JM, Scheffner M and Howley PM. (1991). EMBO J., 10, 4129-4135.
18. Huibregtse JM, Scheffner M and Howley PM. (1993). Mol. Cell. Biol., 13, 775-784.
19. Jeon S and Lambert PF. (1995). Proc. Natl. Acad. Sci. USA, 92, 1654-1658.
20. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. (1992). Science, 256, 827-830.
21. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L and Cho KR. (1993). Proc. Natl. Acad. Sci. USA, 90, 3988-3992.
22. Massimi P, Pim D, Storey A and Banks L. (1996). Oncogene, 12, 2325-2330.
23. Medcalf EA and Milner J. (1993). Oncogene 8, 2847-2851.
24. Munger K, Phelps WV, Bubb V, Howley PM and Schlegel R. (1989). J. Virol., 63, 4417-4421.
25. Pietenpol JA, Tokino T, Thiagalingam S, El-Deiry WS, Kinzler KW and Vogelstein B. (1994). Proc. Natl. Acad. Sci. USA, 91, 1998-2002.
26. Pim D, Storey A, Thomas M, Massimi P and Banks L. (1994). Oncogene, 9, 1869-1876.
27. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
28. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. (1993). Cell, 75, 495-505.
29. Schneider-Gädicke A, Kaul S, Schwarz E, Gausepohl H, Frank R and Bastert G. (1988). Cancer Res., 48, 2969-2974.
30. Schneider-Gädicke A and Schwarz E. (1986). EMBO J., 5, 2285-2292.
31. Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR and Schiller JT. (1991). J. Virol., 65, 4860-4866.
32. Shally M, Alloul N, Jackman A, Muller M, Gissmann L and Sherman L. (1996). Virus Res., 42, 81-96.
33. Shirasawa H, Jin M-H, Shimizu K, Akutsu N, Shino Y and Simizu B. (1994). Virology, 203, 36-42.
34. Smotkin D and Wettstein FO. (1986). Proc. Nat. Acad. Sci. USA, 83, 4680-4684.
35. Smotkin D, Prokoph H and Wettstein FO. (1989). J. Virol., 63, 1441-1447.
36. Stacey SN, Jordan D, Snijders PJF, Mackett M, Walboomers JMM and Arrand JR. (1995). J. Virol., 69, 7023-7031.
37. Storey A, Piccini A, Massimi P, Bouvard V and Banks L. (1995). J. Gen. Virol., 76, 819-826.
38. Thomas M, Massimi P, Jenkins J and Banks L. (1995). Oncogene, 10, 261-268.
39. Thomas M, Matlashewski G, Pim D and Banks L. (1996a). Oncogene, 13, 265-273.
40. Thomas M, Massimi P and Banks L. (1996b). Oncogene, 13, 471-480.
41. Vogelstein B. (1990). Nature, 348, 681-682.
42. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
43. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
44. zur Hausen H and Schneider A. (1987). In NP Salzman and PM Howley (ed.), The papillomaviruses. pp. 245-263. Plenum Publishing Corp., New York.